The Power of Medicinal mushrooms: their therapeutic properties and current medical usage with special emphasis on cancer treatments

Medicinal Mushrooms and Cancer" border="0" height="48" />

"Medicinal mushrooms: their therapeutic properties and current medical usage with special emphasis on cancer treatments."

Authors JOHN E SMITH BSc MSc PhD DSc FIBiol FRSE Emeritus Professor of Applied Microbiology, University of Strathclyde Chief Scientific Officer, MycoBiotech Ltd, Singapore NEIL J ROWAN BSc MSc PhD MIBiol MIFST Lecturer, Department of Bioscience, University of Strathclyde RICHARD SULLIVAN BSc MD PhD Head of Clinical Programmes, Cancer Research UK Introduction Many of the currently available anti-cancer agents are derived form natural products, for instance paclitaxel (Taxol), and camptothecin (Hycamtin) amongst many others. In 2000 Professor Gordon McVie, Director-General of the Cancer Research Campaign (now Cancer Research UK) and Professor John Smith of University of Strathclyde met in Glasgow to discuss the role of medicinal mushrooms in the treatment of cancer. The CRC had become aware that these natural products were being used extensively in the Far East as nutriceuticals (dietary supplements) and as a source for the generation of pharmaceutical-grade medicines to treat a wide variety of diseases, including cancer. The substantial range of medicinal mushroom species from which different bioactive compounds can be derived suggested that the humble mushroom could be a source of novel anti-cancer agents. This monograph is a comprehensive overview of this subject from the technology of cultivation, extraction and chemistry of medicinal mushroom bioactive compounds to the clinical evidence that suggests an important therapeutic role in cancer, and other major diseases. For More about Ganoderma Lucidum go to: HeavenNutrition.OrganoGold.com www.youtube.com/watch?v=9aAjJm4PFuw www.youtube.com/watch?v=xe3qCvaE3U0